Searchable abstracts of presentations at key conferences in endocrinology

ea0050p284 | Neuroendocrinology and Pituitary | SFEBES2017

Non-functioning pituitary macroadenomas: characteristics and outcomes following endoscopic trans-sphenoidal surgery – a single UK tertiary referral centre experience

Seejore Khyatisha , Alavi S Ali , Pearson Sam Matthew , Robins James MW , Tyagi Atul , Nix Paul , Wilson Tom , Phillips Nick , Orme Stephen M , Murray Robert D

Background: Non-functioning pituitary adenomas (NFPA) account for 30-35% of pituitary adenomas. They can lead to hypopituitarism and visual field defects. Trans-sphenoidal resection of pituitary adenoma remains the treatment of choice.Methods: We compared clinical, biochemical, and imaging characteristics of NFPAs at presentation with post-surgical outcomes in a retrospective cohort study. Patients who underwent end...

ea0050p284 | Neuroendocrinology and Pituitary | SFEBES2017

Non-functioning pituitary macroadenomas: characteristics and outcomes following endoscopic trans-sphenoidal surgery – a single UK tertiary referral centre experience

Seejore Khyatisha , Alavi S Ali , Pearson Sam Matthew , Robins James MW , Tyagi Atul , Nix Paul , Wilson Tom , Phillips Nick , Orme Stephen M , Murray Robert D

Background: Non-functioning pituitary adenomas (NFPA) account for 30-35% of pituitary adenomas. They can lead to hypopituitarism and visual field defects. Trans-sphenoidal resection of pituitary adenoma remains the treatment of choice.Methods: We compared clinical, biochemical, and imaging characteristics of NFPAs at presentation with post-surgical outcomes in a retrospective cohort study. Patients who underwent end...

ea0011oc20 | Clinical endocrinology | ECE2006

A European prospective real-life observational study of Quality of Life in patients with acromegaly

Webb SM , Colao A , Caron P , Carvalheiro M , Ertürk E , Pokrajac-Simeunovic A , Schopohl J , Tsagarakis S , Pearson IV , Badia X , Caglio S , Vincenzi B

The primary aim of this study, the largest European, single evaluation, observational trial to date, was to evaluate the impact of acromegaly on health-related quality of life (HRQoL) in patients with biochemically documented active disease, receiving Sandostatin® LAR® at a dose prescribed by their physician for at least 3 months. Secondary objectives were to investigate the relationships between HRQoL and subpopulations based on exploratory var...

ea0063oc12.5 | Endocrine Connections 2 | ECE2019

Sexual desire in transgender persons in relation with gender affirming hormone treatment: Results from ENIGI, a large multicenter prospective cohort study in transgender people

Defreyne Justine , Kreukels Baudewijntje , T'Sjoen Guyt , Heijer Martin Den , Heylens Gunter , Elaut Els

Background: The effect of testosterone on sexual arousal has been described in testosterone withdrawal and re-adminstration studies in birth-assigned males. In birth-assigned females, the relationship between sex steroids and sexual arousal is complex. Several steps in the transitioning process may affect sexual desire: hormone therapy (HT) and gender affirming surgery. HT in transgender men (TM) generally leads to increased sexual desire, masturbation frequency, sexual fantas...

ea0041oc11.1 | Bone & Calcium Homeostasis | ECE2016

An increase of bone mineral density in male-to-female and female-to-male transgender persons after one year cross-sex hormonal treatment

Wiepjes Chantal , Vlot Mariska , Klaver Maartje , de Jongh Renate , Lips Paul , Heijboer Annemieke , Fisher Alessandra , Schreiner Thomas , T'Sjoen Guy , den Heijer Martin

Introduction: Estrogen has positive effects on bone mineral density (BMD), in particular in trabecular bone through inhibition of bone resorption. Testosterone increases bone size, but the effect on BMD is less clear. Cross-sex hormonal treatment (CSHT) in transgender individuals can affect BMD. Therefore, the aim of this study is to investigate effects of CSHT on BMD during the first year of treatment in male-to-female (MtFs) and female-to-male (FtMs) transgender persons....

ea0090ep801 | Pituitary and Neuroendocrinology | ECE2023

An Open-Label Extension Study to Evaluate the Safety of Long-term Use of Relacorilant in Patients With Endogenous Cushing Syndrome

Badiu Corin , Mariash Cary N. , Kautzky-Willer Alexandra , Shlomai Gadi , Aresta Carmen , Pivonello Rosario , Dischinger Ulrich , Bancos Irina , Dobri Georgiana , Hamrahian Amir , Auchus Richard , Feelders Richard , Recasens Monica , Chmiel-Perzynska Iwona , Pearson Emily , Moraitis Andreas G. , Araque Katherine

Cushing syndrome (CS) is a chronic and debilitating condition with high morbidity and mortality. Development of novel, safe, and effective pharmacologic therapies with improved risk-benefit profiles would enrich treatment options for patients. Relacorilant is a selective glucocorticoid receptor (GR) modulator that competitively antagonizes cortisol activity and, unlike the FDA-approved GR antagonist mifepristone, does not bind to the progesterone receptor. In a phase 2 study i...

ea0056p914 | Female Reproduction | ECE2018

The risk of cardiovascular diseases in relation to anthropometric parameters and CRP concentration in a group of women with polycystic ovary syndrome

Zielen-Zynek Iwona , Kowalska Joanna , Nowak Justyna , Kulik-Kupka Karolina , Kulpok Agata , Zubelewicz-Szkodzinska Barbara

Polycystic Ovary Syndrome increases the risk of cardiovascular diseases. To factors predisposing to cardiovascular diseases belong: hypertension, lipid and carbohydrate profiles, smoking and reduced physical activity. The aim of this study was to determine the association between selected factors predisposing to cardiovascular diseases and anthropometric parameters and CRP concentration in women with Polycystic Ovary Syndrome. The study was conducted amongst 43 women, aged 18-...

ea0070oc3.3 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Circulating follistatin predicts type 2 diabetes risk

Wu Chuanyan , Borné Yan , Gao Rui , López Rodriguez Maykel , Roell William , Wilson Jonathan , Ahlqvist Emma , Luan Cheng , Peter Andreas , Machann Jürgen , Hong Mun-Gwan , Schwenk Jochen , Nilsson Peter , Shore Angela , Khan Faisel , Natali Andrea , Melander Olle , Orho-Melander Marju , Nilsson Jan , Renström Erik , Wollheim Claes , Pearson Ewan , Franks Paul , White Morris , Duffin Kevin , Vaag Allan , Laakso Markku , Stefan Norbert , Groop Leif , De Marinis Yang

Follistatin is a hepatokine found to be elevated in patients with type 2 diabetes (T2D) and promotes hyperglycemia in mice. We report that elevated baseline circulating follistatin levels predict future T2D incidence in longitudinal cohorts including up to 5274 individuals. Individuals with elevated circulating follistatin had higher risk of developing type 2 diabetes during follow-up of 4 years (IMI-DIRECT-METSIM, n = 1079, Finland), 5 and 19 years (MDC-CC, n...

ea0020p123 | Thyroid | ECE2009

The outcome of radioiodine therapy in Graves’ hyperthyroidism: thyroid size as prognostic factor

Kijek Jolanta , Tarach Jerzy S , Kurowska Maria , Jankowska Helena

Aim: The aim of the study was the evaluation of the relationship between thyroid size and the result of radioactive iodine therapy in patients treated due to GravesÂ’ hyperthyroidism.Material and methods: The study group included 150 subjects (127 M and 23 F), aged from 20 to 78 years (mean 48.33 years) at the moment of 131I therapy.In all patients the thyroid technetium-99m scan and determination of the serum levels...

ea0035p384 | Diabetes (epidemiology, pathophysiology) | ECE2014

Translating the A1C assay into estimated average fasting glucose values: Data from the 2011 Korea National Health and Nutrition Examination Survey V

Kang Jun Goo , Ohn Jung Hun , Park Ju Ri , Yu Sung Hoon , Ryu Ohk Hyun , Kim Chul Sik , Lee Seong Jin , Hong Eun Gyoung , Kim Doo-Man , Yoo Jae Myung , Ihm Sung Hee , Choi Moon Gi , Yoo Hyung Joon

Aim: An international expert committee, after considering data on association of HbA1c and retinopathy, recommended that diabetes be diagnosed when HbA1c is more than 48 mmol/mol (>6.5%), provided this assay is done in a standardized laboratory. However, the performance of HbA1c in detecting diabetes in the Korean population remains unknown. The purpose of this study was to evaluate the efficiency of HbA1c in diagnosing diabetes and to identify the optimal threshold in the...